Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03520946
Title RAMucirumab in Combination Wth TAS102 vs. TAS102 Alone in Chemotherapy Refractory Metastatic Colorectal Cancer Patients (RAMTAS)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications

colon adenocarcinoma

rectum adenocarcinoma

colorectal cancer

Therapies

Ramucirumab + Trifluridine-tipiracil hydrochloride

Trifluridine-tipiracil hydrochloride

Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.